As compared with control, the average tumor volume of the LV-miR203-treated group was markedly reduced by more than 65% and LV-miR-203 and pcDNA-CASK treated group exhibited significantly larger tumors (Figure 5A and 5B). Here, CASK is linked to neoplasm.